<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03402191</url>
  </required_header>
  <id_info>
    <org_study_id>Prof Elshanshoury</org_study_id>
    <nct_id>NCT03402191</nct_id>
  </id_info>
  <brief_title>L-arginine Versus Sildenafil in Children With Beta Thalassemia Associated With Pulmonary Hypertension</brief_title>
  <official_title>Comparative Clinical Study Evaluating the Effect of L-arginine Versus Sildenafil in Children With Beta Thalassemia Associated With Pulmonary Hypertension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tanta University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tanta University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study compares L-arginine Versus Sildenafil as treatment for pulmonary hypertension in
      Children with Beta Thalassemia
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study focuses on different lines of treatment for pulmonary hypertension in children
      with thalassemia as this study discusses the Effect of L-arginine Versus Sildenafil in
      Children with Beta Thalassemia Associated with Pulmonary Hypertension
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 2016</start_date>
  <completion_date type="Anticipated">December 2023</completion_date>
  <primary_completion_date type="Anticipated">December 2023</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patients with improvement of pulmonary hypertension</measure>
    <time_frame>6 months</time_frame>
    <description>patients with improvement of pulmonary hypertension</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Thalassemia</condition>
  <arm_group>
    <arm_group_label>L-arginine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>l-arginine for pulmonary hypertension in patients with thalassemia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sildenafil</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Sildenafil for pulmonary hypertension in patients with thalassemia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No pulmonary hypertension</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>L-arginine</intervention_name>
    <description>l-arginine for thalassemia with pulmonary hypertension</description>
    <arm_group_label>L-arginine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sildenafil</intervention_name>
    <description>Sildenafil for thalassemia with pulmonary hypertension</description>
    <arm_group_label>Sildenafil</arm_group_label>
    <other_name>Viagra</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children with thalassemia and pulmonary hypertension.

        Exclusion Criteria:

          -  Rheumatic heart diseases.

          -  Other comorbid disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sahar El-Haggar, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tanta University - Faculty of Pharmacy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mohamed El-Shanshoury, Prof</last_name>
    <role>Study Director</role>
    <affiliation>Tanta University Pediatrics Department</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Osama Abd-rab El-Rasol, Prof</last_name>
    <role>Study Chair</role>
    <affiliation>Tanta University Pediatrics Department</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tarek Mostafa, Ass Prof</last_name>
    <role>Study Chair</role>
    <affiliation>Tanta University-Faculty of pharmacy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eman El-Khateeb, Msc</last_name>
    <role>Study Chair</role>
    <affiliation>Tanta University-Faculty of pharmacy</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sherief Abd-Elsalam, MD</last_name>
    <phone>00201095159522</phone>
    <email>sheriefabdelsalam@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Sherief Abd-Elsalam</name>
      <address>
        <city>Tanta</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sherief Abd-elsalam, lecturer</last_name>
      <phone>00201000040794</phone>
      <email>Sherif_tropical@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 9, 2018</study_first_submitted>
  <study_first_submitted_qc>January 16, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 18, 2018</study_first_posted>
  <last_update_submitted>January 16, 2018</last_update_submitted>
  <last_update_submitted_qc>January 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 18, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Hypertension, Pulmonary</mesh_term>
    <mesh_term>Thalassemia</mesh_term>
    <mesh_term>beta-Thalassemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sildenafil Citrate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

